# Duplication of the prothrombin gene is associated with a significant increase in thrombin generation

**Authors:** Annelie Siegemund, Thomas Siegemund, Hagen Bönigk, Kristina Schlosser, Katja Konn, Sabine Keil, Sirak Petros

PMC · DOI: 10.1016/j.rpth.2026.103386 · Research and Practice in Thrombosis and Haemostasis · 2026-02-02

## TL;DR

A woman with a duplication in her prothrombin gene had increased blood clotting risk, a new finding in thrombosis research.

## Contribution

This is the first reported case of a full prothrombin gene duplication linked to hypercoagulability.

## Key findings

- The duplication encompassed the entire prothrombin gene and six adjacent protein-coding genes.
- The duplication was associated with markedly increased prothrombin levels and thrombin generation.
- The patient had a history of unprovoked arterial and venous thrombotic episodes.

## Abstract

Prothrombin gene mutations can be associated with either a thrombotic or a bleeding risk. Genomic studies and coagulation workup can provide valuable information to better understand their clinical importance.

We describe the case of a woman with a duplication of the entire prothrombin gene.

A 42-year-old woman presented for thrombophilia screening following a history of unprovoked arterial and superficial venous thrombotic episodes. Coagulation workup demonstrated a marked increase in prothrombin levels and ex vivo thrombin generation. Genetic analysis revealed a duplication of at least 307.9 kb (maximum 366.7 kb): arr[ChRCh38]:11p11.2(46,455,533-46,763,446)x3, encompassing the entire prothrombin gene and 6 adjacent protein-coding genes (HARBI1, ATG13, ARHGAP1, and ZNF408 completely involved, and AMBRA1 and CKAP5 partially involved).

The present case demonstrated duplication of the entire prothrombin gene, associated with a significant hypercoagulable risk, a finding not previously reported in the literature.

•A prothrombin gene duplication was detected in a woman with a history of unprovoked thromboses.•Gene analysis revealed a duplication of at least 307.9 kb (maximum 366.7 kb).•This duplication encompassed the entire prothrombin gene and 6 adjacent protein-coding genes.•The mutation was associated with markedly increased prothrombin levels and thrombin generation.

A prothrombin gene duplication was detected in a woman with a history of unprovoked thromboses.

Gene analysis revealed a duplication of at least 307.9 kb (maximum 366.7 kb).

This duplication encompassed the entire prothrombin gene and 6 adjacent protein-coding genes.

The mutation was associated with markedly increased prothrombin levels and thrombin generation.

## Linked entities

- **Genes:** F2 (coagulation factor II, thrombin) [NCBI Gene 395306], HARBI1 (harbinger transposase derived 1) [NCBI Gene 283254], ATG13 (autophagy related 13) [NCBI Gene 9776], ARHGAP1 (Rho GTPase activating protein 1) [NCBI Gene 392], ZNF408 (zinc finger protein 408) [NCBI Gene 79797], AMBRA1 (autophagy and beclin 1 regulator 1) [NCBI Gene 55626], CKAP5 (cytoskeleton associated protein 5) [NCBI Gene 9793]
- **Diseases:** thrombosis (MONDO:0000831), hypercoagulability (MONDO:0002305)

## Full-text entities

- **Genes:** ARHGAP1 (Rho GTPase activating protein 1) [NCBI Gene 392] {aka CDC42GAP, RHOGAP, RHOGAP1, p50rhoGAP}, AMBRA1 (autophagy and beclin 1 regulator 1) [NCBI Gene 55626] {aka DCAF3, WDR94}, CKAP5 (cytoskeleton associated protein 5) [NCBI Gene 9793] {aka CHTOG, MSPS, TOG, TOGp, ch-TOG}, ZNF408 (zinc finger protein 408) [NCBI Gene 79797] {aka EVR6, PRDM17, RP72}, F5 (coagulation factor V) [NCBI Gene 2153] {aka FVL, PCCF, RPRGL1, THPH2, fV}, HARBI1 (harbinger transposase derived 1) [NCBI Gene 283254] {aka C11orf77}, ATG13 (autophagy related 13) [NCBI Gene 9776] {aka KIAA0652, PARATARG8}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** trauma (MESH:D014947), pulmonary embolism (MESH:D011655), TG (MESH:D019851), bleeding (MESH:D006470), arterial and superficial venous thrombotic (MESH:D020246), artery (MESH:D012078), venous thromboembolism (MESH:D054556), thromboses (MESH:D013927), prothrombin deficiency (MESH:D007020), thrombophlebitis (MESH:D013924)
- **Chemicals:** phenprocoumon (MESH:D010644), Z-Gly-Gly- Arg-AMC (MESH:C411346), EDTA (MESH:D004492), CaCl2 (MESH:D002122), fondaparinux (MESH:D000077425), aspirin (MESH:D001241), vitamin K (MESH:D014812), 7-amino-4-methylcoumarin (MESH:C028743), TG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G21010A, G20210A, c.1323A>G, p.Ile441Met

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945570/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12945570/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945570/full.md

---
Source: https://tomesphere.com/paper/PMC12945570